The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially preterm babies and infants under six months old. The younger the child, the ...

“As the industry transitions from traditional drug discovery and life sciences R&D to faster-paced, complex modalities, ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine mRESVIA, designed to prevent lower respiratory tract disease (LRTD) caused ...

The V4 engine has been updated to deliver 220 bhp, making the 2025 Aprilia RSV4 the most powerful homologated production superbike in the world.

This year's headlines on respiratory syncytial virus (RSV) focused largely on the relatively new vaccines -- including a new ...

The 2025 Aprilia RSV4 and RSV4 Factory were introduced at the EICMA 2024. The superbikes received a few updates for next year ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

When MRNA reports third-quarter earnings, investors will likely focus on the sales performance of its recently approved RSV ...

A 2025 Aprilia RSV4 Factory. Photos courtesy Aprilia. At EICMA 2024, Aprilia and Moto Guzzi confirm the renewal and expansion of their range of motorbikes. From sporty riding to touring and from race ...

Ducati debuted the biggest update for the Panigale V4 just months ago, while BMW recently revamped the S 1000 RR with some nitty-gritty yet crucial changes. Keeping the trend going now is Noale-based ...

I learned about Pacaso's model over the last year, and I'd be lying if I said I wasn't scheming daily about investing in a vacation home. The model is so good. Knowing that they've expanded into the ...